Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study · Schwartzmann B, Quilty LC, Dhami P et al.

Discussion

In this study, we showed that resting-state EEG delta and alpha power might have possibly moderate to strong predictive utility in predicting response to CBT for adults with depression.

A reduced baseline delta power was observed in responders and was predictive of response to CBT. Responders also exhibited an early increase in delta power, which also proved to be a good predictor of response to the therapy. While previous authors have also reported an association between slow oscillations and response to other antidepressant treatment modalities20,21,23–28, results are not unidirectional and may be related to different effects and mechanisms of antidepressants and different subtypes within depression. Here, the findings in the delta activity might reflect cognitive control changes, which have been attributed to the mechanisms of CBT53–57. Previous studies have shown the functional significance of delta activity during cognitive processing59–67. For example, delta oscillations may play a role in motivational and emotional processes61,66 and also in inhibitory control and response inhibition59,60,63,65,67. An increase in delta activity may also be an indicator of attention to internal processing during the performance of a mental task62. Regarding delta activity at rest, some previous studies reported the relevance of low-frequency intrinsic activity in the neural mechanisms of cognitive control processes68–70. In these studies, resting-state delta power was shown to be associated with behavioral performance and neural correlates of response inhibition during a go/no-go task. In another recent study, resting-state delta oscillations were predictive of good performance on an attentional set-shifting task71. The results here could suggest that CBT enhances cognitive control manipulation processes in patients who display an increase in delta activity after 2 weeks of therapy. Moreover, some studies involving meditation also reported an increase in delta activity during the suppression of interference72,73. In these studies, stronger delta activity in the medial prefrontal cortex, during the eyes-closed resting state, was suggested to reflect a reduction of emotional and cognitive engagement. The findings here could suggest that patients with stronger emotional engagement at baseline represent a subgroup who responds well to CBT. This correlates with a study in which patients presenting excessive attention toward aversive information were more likely to respond to CBT74. Increased attention to aversive stimuli is suggested to be a mechanism underlying emotional disorders in patients with depression75. The early increase in delta observed here in responders to CBT could therefore reflect a mechanism whereby CBT reduces negative emotional engagement that interferes with decision making and situational goals. Furthermore, when investigating if differences observed in early changes were associated with improvements in specific symptoms using subdomains of MADRS, early increases in delta were found to be related to improvement in sadness, and negative thoughts subdomains (Supplementary Fig S5). In comparison, early decreases in alpha were not related to any subdomains. While further analyses are necessary to better understand the role of delta oscillations, these results support the potential link between delta activity and cognitive control when processing negative information.

A significant difference was also found in the early changes in relative alpha power, with a decrease observed in responders. This change was found to have strong utility in predicting response to CBT. Reduction in alpha power has been shown to be a mechanistic marker of response to various modalities of antidepressant treatments (including medications, rTMS and ECT) across studies20,21,28,34,47. There is an inverse relationship between alpha power and cortical activity76,77. Hence, a decrease in alpha power could reflect an increase in cortical arousal toward the processing of external stimuli and cognitive engagement instead of an internally self-focused emotional processing78–81. Moreover, as this change was primarily over regions in left hemisphere, it could also indicate that cognitive therapies, which are highly verbal treatments, may involve cognitive processes meditated by regions in left hemisphere. This is in line with studies that found a left hemisphere advantage for verbal processing in responders to CBT50–52.

Altogether, it is possible that CBT may be better suited for individuals with overactive cognitive presentations. In this study, responders to the therapy were found to be more likely to exhibit lower delta activity and higher alpha activity, which could indicate greater inward-focused and self-referential processing. By using CBT to alter thought patterns, it might be possible to induce changes in brain activity, leading to improved mood and emotional states.

This study has certain limitations worth noting. First, considering the small sample size, any generalization from the findings should be made with caution. It also precludes the analysis of gender-based effects or other potential moderators such as ethnicity or clinical features. Secondly, placebo effects are unknown as findings were obtained during an open-label treatment. Replication of the results in a larger sample size and with a treatment control group is required. It would also inform the quantification of the differences in EEG predictors across treatment modalities.

In summary, this is the first study to show findings possibly indicated a potential utility of resting EEG in predicting response to CBT for adults with depression. The findings suggest that baseline measures and early changes in delta and alpha frequency bands might be used to classify responders and non-responders to CBT. While baseline measures might not be enough to predict CBT treatment outcomes accurately, information that arises during the early course of therapy was found to be a strong predictor of response to CBT. Given the limited access to in-person CBT therapy and the limited number of CBT therapists, being able to make an informative decision after the two first weeks of therapy about whether to continue or switch to another treatment would have great clinical value. EEG technology is becoming more accessible with more portable and less expensive devices82,83, and research investigating EEG-based biomarkers can inform its strategic application in clinical contexts. Future studies are required in order to validate the results, but the insight gained here may help the development of objective clinical decision tools to guide individual patients with MDD to the optimal treatment.